Asymptomatic HIV testing in Giovinazzo

Find health labs to test for Asymptomatic HIV in Giovinazzo and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via G. Matteotti, 24 70121 Bari (BA)

11 km

Unverified

See Details

HIV Test by Lab. Point

Via della Resistenza, 188, 70125 Bari BA, Italia

11 km

Unverified

See Details

HIV Test by Centro Polispecialistico Futura Diagnostica Srl

Corso Vittorio Emanuele, 190, 70019 Triggiano BA, Italia

15.6 km

Verified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Giuseppe Palmitessa, 18 76121 Barletta (BA)

22.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Ferdinando D’Argona, 92/B 76121 Barletta (BAT)

22.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Vico Wan Westerhout 10, 70042 Mola di Bari BA 70042 Mola di Bari (BA)

23 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Casamassima, 122/C 70010 Turi (BA)

26.1 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Scipione Ronchetti, 15 70022 Altamura (BA)

25.7 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Piazza Cavour, 27 70024 Gravina in Puglia (BA)

28.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Contrada Fratta, sn 70044 Polignano (BA)

31.5 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.